Literature DB >> 17460724

Heritability of serum hs-CRP concentration and 5-year changes in the Stanislas family study: association with apolipoprotein E alleles.

H Berrahmoune1, B Herbeth, G Siest, S Visvikis-Siest.   

Abstract

We aimed at estimating additive genetic heritability, household component effect and the influence of common alleles of the apolipoprotein E gene (APOE) on serum high-sensitivity C-reactive protein (hs-CRP) concentrations and the subsequent changes over 5 years. A sub-sample of 320 nuclear families was randomly selected from the Stanislas Family Study. Serum hs-CRP concentration was measured by immunonephelometry at entrance and after 5 years. APOE alleles were determined by restriction fragment length polymorphism. After adjustment for covariates, the number of the epsilon4 allele was negatively associated with serum concentration of hs-CRP in the whole sample, at entrance and 5 years later, without significant interaction with sex by generation groups (P=0.003 and P=0.0003, respectively). However, no significant association was found between epsilon4 allele and 5-year changes in hs-CRP concentration. Using a variance component analysis, no significant genetic influence was shown in family aggregation of both hs-CRP measurements and 5-year changes; the household common component was between 6.5 and 12.8%. In addition, after adjustment for APOE gene polymorphisms, degrees of resemblance were almost unchanged. In the Stanislas Family Study, epsilon4 allele of the APOE gene was associated with lower hs-CRP concentration, but not with 5-year changes. However, variance component analysis did not evidence a significant polygenic effect.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460724     DOI: 10.1038/sj.gene.6364395

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  6 in total

Review 1.  Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.

Authors:  Weijing He; John Castiblanco; Elizabeth A Walter; Jason F Okulicz; Sunil K Ahuja
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

2.  Apolipoprotein E genotype is associated with serum C-reactive protein but not abdominal aortic aneurysm.

Authors:  Jonathan Golledge; Erik Biros; Matthew Cooper; Nicole Warrington; Lyle J Palmer; Paul E Norman
Journal:  Atherosclerosis       Date:  2009-09-25       Impact factor: 5.162

3.  APOE Polymorphism Is Associated with C-reactive Protein Levels but Not with White Blood Cell Count: Dong-gu Study and Namwon Study.

Authors:  Yong-Woon Yun; Sun-Seog Kweon; Jin-Su Choi; Jung-Ae Rhee; Young-Hoon Lee; Hae-Sung Nam; Seul-Ki Jeong; Kyeong-Soo Park; So-Yeon Ryu; Seong-Woo Choi; Hee Nam Kim; Jane A Cauley; Min-Ho Shin
Journal:  J Korean Med Sci       Date:  2015-06-10       Impact factor: 2.153

4.  APOE polymorphism and its effect on plasma C-reactive protein levels in a large general population sample.

Authors:  Jaroslav A Hubacek; Anne Peasey; Hynek Pikhart; Petr Stavek; Ruzena Kubinova; Michael Marmot; Martin Bobak
Journal:  Hum Immunol       Date:  2010-01-25       Impact factor: 2.850

Review 5.  Are there genetic paths common to obesity, cardiovascular disease outcomes, and cardiovascular risk factors?

Authors:  Tuomo Rankinen; Mark A Sarzynski; Sujoy Ghosh; Claude Bouchard
Journal:  Circ Res       Date:  2015-02-27       Impact factor: 17.367

Review 6.  Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals.

Authors:  Tauseef A Khan; Tina Shah; David Prieto; Weili Zhang; Jackie Price; Gerald R Fowkes; Jackie Cooper; Philippa J Talmud; Steve E Humphries; Johan Sundstrom; Jaroslav A Hubacek; Shah Ebrahim; Debbie A Lawlor; Yoav Ben-Shlomo; Mohammad R Abdollahi; Arjen J C Slooter; Zoltan Szolnoki; Manjinder Sandhu; Nicholas Wareham; Ruth Frikke-Schmidt; Anne Tybjærg-Hansen; Gerda Fillenbaum; Bastiaan T Heijmans; Tomohiro Katsuya; Grazyna Gromadzka; Andrew Singleton; Luigi Ferrucci; John Hardy; Bradford Worrall; Stephen S Rich; Mar Matarin; John Whittaker; Tom R Gaunt; Peter Whincup; Richard Morris; John Deanfield; Ann Donald; George Davey Smith; Mika Kivimaki; Meena Kumari; Liam Smeeth; Kay-Tee Khaw; Michael Nalls; James Meschia; Kai Sun; Rutai Hui; Ian Day; Aroon D Hingorani; Juan P Casas
Journal:  Int J Epidemiol       Date:  2013-04       Impact factor: 7.196

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.